131 results on '"Mire-Sluis, Anthony"'
Search Results
2. Biological Activity Assays for Antibody Therapeutics
3. Biological Activity Assays for Antibody Therapeutics
4. Monoclonal Antibody Therapeutics: The Need for Biopharmaceutical Reference Materials
5. Bioanalytical Method Validation for Macromolecules in Support of Pharmacokinetic Studies
6. Characterizing biological products and assessing comparability following manufacturing changes
7. Progress in the Use of Biological Assays During the Development of Biotechnology Products
8. Scientific and regulatory considerations on the immunogenicity of biologics
9. Quality Considerations for Recombinant DNA-Derived Biological Therapeutic Products: A Control Perspective on Cytokines
10. The Steel Factor/kit Ligand/Stem Cell Factor
11. Interleukin-7
12. Interleukin-4
13. Interleukin-16
14. Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value
15. Cytokines: from technology to therapeutics
16. Advances in the assessment and control of the effector functions of therapeutic antibodies
17. Handbook of Experimental Pharmacology, vol. 95, Peptide Growth Factors and Their Receptors I and II
18. Meeting report on protein particles and immunogenicity of therapeutic proteins: Filling in the gaps in risk evaluation and mitigation
19. Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
20. Interleukins
21. Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics
22. Constructing an Immunogenicity Risk Assessment for Follow-On Biologics
23. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products
24. Implications for the assay and biological properties of interleukin-3. Results of a WHO international collaborative study
25. Implications for the assay and biological activity of interleukin-4. Results of a WHO international collaborative study
26. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega
27. Interleukins
28. Biological Standardization and Control at the World Health Organization: Successes, Current Issues and Future Challenges
29. Development of a continuous IL-7-dependent murine pre-B cell line PB-1 suitable for the biological characterisation and assay of human IL-7
30. Development of a Lyophilization Formulation that Preserves the Biological Activity of the Platelet-inducing Cytokine Interleukin-11 at Low Concentrations
31. The development of a World Health Organisation international standard for islet cell antibodies: the aims and design of an international collaborative study
32. Recombinant Human Albumin as a Stabilizer for Biological Materials and for the Preparation of International Reference Reagents
33. WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents
34. Blood Polymorphonuclear Leukocytes From the Majority of Sickle Cell Patients in the Crisis Phase of the Disease Show Enhanced Adhesion to Vascular Endothelium and Increased Expression of CD64
35. Implications for the assay and biological activity of interleukin-8: results of a WHO international collaborative study
36. Biological Assays: Their Role in the Development and Quality Control of Recombinant Biological Medicinal Products
37. An anti-cytokine bioactivity assay for interferons-α, -β and -ω
38. The Biological Properties, Assay, and Standardization of Interferon-Alpha: A Need for a WHO Collaborative Study
39. Implications for the assay and biological activity of interleukin-4 Results of a WHO international collaborative study
40. Implications for the assay and biological properties of interleukin-3 Results of a WHO international collaborative study
41. An evaluation of the stability of granulocyte colony stimulating factor on short-term storage and delivery from an elastomeric infusion system
42. Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors
43. An antiproliferative bioassay for interleukin-4
44. Quantitative cell line based bioassays for human cytokines
45. Immunoassays for detecting cytokines: What are they really measuring?
46. The international standard for macrophage colony stimulating factor (M-CSF) Evaluation in an international collaborative study
47. The international standard for granulocyte colony stimulating factor (G-CSF) Evaluation in an international collaborative study
48. The international standard for granulocyte-macrophage colony stimulating factor (GM-CSF) Evaluation in an international collaborative study
49. Transforming growth factor-β1 blocks interleukin 4 induced cell proliferation by inhibiting a protein tyrosine phosphatase essential for signal transduction
50. A novel, sensitive bioassay for transforming growth factor β
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.